| Patent Number | Title | Applicant | Opposition Date |
|---|---|---|---|
| EP3626270 | New Use | NOVARTIS AG | Jul 10, 2024 |
| EP3042669 | Antitumor Agent And Antitumor Effect Enhancer | TAIHO PHARMACEUTICAL CO., LTD. | Nov 29, 2023 |
| EP3294283 | Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure | NOVARTIS AG | Nov 23, 2023 |
| EP3003360 | High Potency Pancreatin Pharmaceutical Compositions | ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED | Jul 6, 2021 |
Feel free to send us a message here and we will get back to you